Kind attn: Durganand Pathak

[Guest guest]

Hi,

What is the meaning of this post from you? It does not make any sense to me.

Vijay

> >>

> >> v     Researchers testing a new treatment for tuberculosis in a

developing country discover some patients have HIV infection. Do they have a

responsibility to provide antiretroviral drugs?

> >>  

> >> v     Malaria researchers may detect that their juvenile

subjects are suffering from schistosomiasis, a serious parasitic disease common

in many malarial areas. Do the researchers have a responsibility to treat the

schistosomiasis?

> >>  

> >> Such questions about researchers' responsibilities to provide ancillary

clinical care arise pervasively, yet there is an almost total absence of

guidance.

> >>  

> >>  

> >> Ancillary care is that which is not required to make a study scientifically

valid, to ensure a trial's safety, or to redress research injuries. Thus,

stabilising patients to enroll them in a research protocol, monitoring drug

interactions, or treating adverse reactions to experimental drugs are not a part

of ancillary care.

> >>

> >>  

> >> In general, when do researchers have a responsibility to provide clinical

care to participants that is not stipulated in the trial's protocol?

> >>

> >>  

> >>   There is a difference of opinion when answer to this question is

concerned.

> >>  

> >> Some researchers feel  that they must provide whatever ancillary care

their participants need. From an ethical perspective, this response makes sense.

Research participants in trials in the developing world are usually desperately

poor and ill, and everyone arguably has a duty to rescue those in need, at least

when they can do so at minimal cost to themselves.

> >>  

> >> When researchers consider that offering ancillary care this broadly may

drain limited human and financial resources and confound study results, they

tend to retreat from this position.

> >>  

> >> Some researchers veer to the opposite extreme.  They opine that the

 research participants are not their patients, so they don’t  owe

them anything beyond what is needed to complete the study safely and

successfully†" that is, they don’t owe them ancillary care. But this

extreme position is ethically questionable.

> >>  

> >>  

> >> Another problem is that acceptance of ancillary care responsibilities for

research subjects from economically poor countries might coerce them into

participating in the study and induce a strong element of volunteer bias. This

practice of offering medical care in exchange for study participation would be

no different to the payment of research subjects (in fact, it could mean greater

financial incentives for poorer subjects), and has ethical implications.

> >>  

> >>  

> >> Keeping the arguments and controversy apart, let us understand that those

involved in clinical research, whether individual or collective, have duties to

rescue those in need. For instance, everyone has a duty to help a person who is

in need and whom no one else can help, at least when one can provide the help

without serious sacrifice or risk. (1) Even if one's ability to help is not

strictly unique, an urgent need can generate a duty to help when it is

predictable that no one else will. (2) These duties are quite general and

generate moral demands not only on individual researchers' medical skills but

also on the collective financial  resources of the research team and its

sponsors.

> >>  

> >>  

> >> Dr Smita

> >>

> >>

> >> The INTERNET now has a personality. YOURS! See your Homepage.

http://in.. com/

> >>

> >

> >

>

> ________________________________

> The INTERNET now has a personality. YOURS! See your Homepage.

>

> hello i am durgananddddddddddddddd pathak

>